BAVENCIO FDA approval date

The FDA approved BAVENCIO on 23 Mar 2017.

FDA approval date
23 Mar 2017

Drug identity has not yet been verified against registry records

Also recorded as AVELUMAB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-03-23DayBAVENCIOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761049", "applicant_as_listed_by_fda": "EMD SERONO INC", "brand_names": ["BAVENCIO"], "active_ingredients": ["AVELUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170323", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026